ERIN GERKEN: Open Payments
NPI 1669062964 · ROSSFORD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 35 payments from 15 companies in 2025. Trend: 2023 $1,384 · 2024 $1,531 · 2025 $1,279
Food & beverage: $1,279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $442 |
| Teva Pharmaceuticals USA, Inc. | 6 | $181 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $120 |
| Novo Nordisk Inc | 1 | $91 |
| Lilly USA, LLC | 1 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
Products named: VRAYLAR, AUSTEDO XR, ULTOMIRIS, LUMRYZ, Wegovy, KISUNLA, QULIPTA, INGREZZA.
Industry payments across OH — which companies pay providers there.
